At Roche Pharmaceuticals, we focus on finding new medicines that help patients live longer, better lives and evolve the practice of medicine.

This page lists Roche Australia’s pharmaceutical medicines. Use the search function to search by active ingredient, brand name or disease area, to find the Product Information (PI) and Consumer Medicine Information (CMI) for each product.

Actemra® (tocilizumab)

Actemra® (tocilizumab)

Availability of Actemra® (tocilizumab):

  • Pre-filled syringe for subcutaneous (SC) injection
  • Pre-filled pen for subcutaneous (SC) injection
  • Intravenous (IV) solution for infusion

Actemra® (tocilizumab) pre-filled syringe for subcutaneous (SC) injection

Patients
Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Actemra® (tocilizumab) pre-filled pen for subcutaneous (SC) injection

Patients
Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Actemra® (tocilizumab) intravenous (IV) solution for infusion

Patients
Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Alecensa® (alectinib)

Alecensa® (alectinib)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Avastin® (bevacizumab)

Avastin® (bevacizumab)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Bactrim® (sulfamethoxazole and trimethoprim)

Bactrim® (sulfamethoxazole and trimethoprim)

Roche has discontinued the supply of Bactrim (sulfamethoxazole/trimethoprim) oral suspension 200 mg/ 40 mg per 5 mL and Bactrim DS tablets 800/160mg. Stock of Bactrim oral suspension has now been depleted and it is anticipated that stock of Bactrim tablets will be depleted by end of July 2019. Alternative brands of sulfamethoxazole/trimethoprim are available from generic manufacturers.

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

CellCept® (mycophenolate mofetil)

CellCept® (mycophenolate mofetil)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Cotellic® (cobimetinib)

Cotellic® (cobimetinib)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Cymevene® (ganciclovir)

Cymevene® (ganciclovir)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Erivedge® (vismodegib)

Erivedge® (vismodegib)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Esbriet® (pirfenidone)

Esbriet® (pirfenidone)

Availability of Esbriet® (pirfenidone):

  • Tablets
  • Capsules

Esbriet® (pirfenidone) tablets

Patients
Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Esbriet® (pirfenidone) capsules

Patients
Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Fuzeon® (enfuvirtide)

Fuzeon® (enfuvirtide)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Gazyva® (obinutuzumab)

Gazyva® (obinutuzumab)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Hemlibra® (emicizumab)

Hemlibra® (emicizumab)

Patients
Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Herceptin® (trastuzumab) powder for IV infusion

Herceptin® (trastuzumab) powder for IV infusion

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Herceptin® SC (trastuzumab) solution for SC injection

Herceptin® SC (trastuzumab) solution for SC injection

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Hypnovel® (midazolam)

Hypnovel® (midazolam)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals 
Product Information (PI)

Invirase® (saquinavir)

Invirase® (saquinavir)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals

Product Information (PI)

Kadcyla® (trastuzumab emtansine)

Kadcyla® (trastuzumab emtansine)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Konakion® MM (phytomenadione)

Konakion® MM (phytomenadione)

In November 2018, Roche transferred the sponsorship and management of supply, customer support, medical information, regulatory services, sales and marketing of Konakion® MM (phytomenadione) to Pharmaco (Australia) Ltd within Australia.

The current Consumer Medicine Information (CMI) and Product Information (PI) for Konakion are available from the Therapeutic Goods Administration (TGA) website at: http://www.tga.gov.au/

Konakion® MM Paediatric (phytomenadione)

Konakion® MM Paediatric (phytomenadione)

In November 2018, Roche transferred the sponsorship and management of supply, customer support, medical information, regulatory services, sales and marketing of Konakion® MM (phytomenadione) to Pharmaco (Australia) Ltd within Australia.

The current Consumer Medicine Information (CMI) and Product Information (PI) for Konakion are available from the Therapeutic Goods Administration (TGA) website at: http://www.tga.gov.au/

Lariam® (mefloquine)

Lariam® (mefloquine)

In August 2018, Roche transferred the sponsorship and management of supply, customer support, medical information, regulatory services, sales and marketing of Lariam (mefloquine) to Pharmaco (Australia) Limited within Australia.

Lexotan® (bromazepam)

Lexotan® (bromazepam)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

MabThera® (rituximab) solution for IV infusion

MabThera® (rituximab) solution for IV infusion

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

MabThera® SC (rituximab) solution for SC injection

MabThera® SC (rituximab) solution for SC injection

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Madopar® (levodopa and benserazide)

Madopar® (levodopa and benserazide)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Mircera® (methoxy polyethylene glycolepoetin beta)

Mircera® (methoxy polyethylene glycolepoetin beta)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals 
Product Information (PI)

NeoRecormon® (epoetin beta)

NeoRecormon® (epoetin beta)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Ocrevus® (ocrelizumab)

Ocrevus® (ocrelizumab)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Pegasys® (peginterferon alfa-2a)

Pegasys® (peginterferon alfa-2a)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Perjeta® (pertuzumab)

Perjeta® (pertuzumab)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Pulmozyme® (dornase alfa)

Pulmozyme® (dornase alfa)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Rivotril® (clonazepam)

Rivotril® (clonazepam)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Roaccutane® (isotretinoin)

Roaccutane® (isotretinoin)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Rocaltrol® (calcitriol)

Rocaltrol® (calcitriol)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Roferon-A® (interferon alfa-2a)

Roferon-A® (interferon alfa-2a)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals 
Product Information (PI)

Tamiflu® (oseltamivir) capsules

Tamiflu® (oseltamivir) capsules

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Tamiflu® (oseltamivir) suspension

Tamiflu® (oseltamivir) suspension availability - 26 June 2019

Roche is experiencing high seasonal demand for Tamiflu® (oseltamivir) due to the current influenza outbreak. As a result of this increased demand, Roche is anticipating a temporary shortage of Tamiflu 6 mg/ml suspension during July. Tamiflu continues to be available in 30mg, 45mg and 75mg capsules to treat cases of influenza throughout Australia.

Where no suspension is available, Tamiflu capsules may be compounded by a pharmacy. Pharmacists should refer to instructions in the Tamiflu capsules Product Information or the How to prepare Tamiflu suspension information sheet.

Roche is working closely with its global supply chain team to secure additional stock, and with its distribution partner, Apotex, to expedite deliveries to ensure wholesalers have the stock they need. Wholesalers are advised to contact Apotex, for further information on supply of Tamiflu. Pharmacists are advised to contact their usual wholesaler, or an alternative wholesaler, in the event that they cannot secure supply. Pharmacists may also contact Apotex Customer Services directly on 1800 276 839 or by email at: customer.service.aus@apotex.com to identify an alternative wholesaler.

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Tarceva® (erlotinib)

Tarceva® (erlotinib)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Tecentriq® (atezolizumab)

Tecentriq® (atezolizumab)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Valcyte® (valganciclovir) powder for oral solution

Valcyte® (valganciclovir) powder for oral solution

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Valcyte® (valganciclovir) tablets

Valcyte® (valganciclovir) tablets

Patients
Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Valium® (diazepam)

Valium® (diazepam)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Xenical® (orlistat)

Xenical® (orlistat)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)

Zelboraf® (vemurafenib)

Zelboraf® (vemurafenib)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI)